ANN ARBOR, Mich.--Eli Lilly has launched an 18-month software development program with Nonlinear Dynamics here that is designed to accelerate Lilly's drug discovery process. A team of six Nonlinear research scientists will work with chemoinformatics specialists at Lilly to develop datamining software to help reduce the time and expense required to identify high-potential compounds for further drug development and preclinical evaluation. Pilot testing of Nonlinear's preproduction software is scheduled to begin later this year, according to Lilly.
Nonlinear specializes in applying nonlinear analytic methods to automate complex business, technical, and data processing tasks. The company's analytical approaches emphasize datamining of very large databases; pattern recognition in text, image, and other domains; and natural language processing.